Cargando…

Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study

Objective To quantify and compare the treatment effect and risk of bias of trials reporting biomarkers or intermediate outcomes (surrogate outcomes) versus trials using final patient relevant primary outcomes. Design Meta-epidemiological study. Data sources All randomised clinical trials published i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciani, Oriana, Buyse, Marc, Garside, Ruth, Pavey, Toby, Stein, Ken, Sterne, Jonathan A C, Taylor, Rod S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558411/ https://www.ncbi.nlm.nih.gov/pubmed/23360719 http://dx.doi.org/10.1136/bmj.f457

Ejemplares similares

Treatment effect bias in randomised controlled trials using surrogate outcomes: a preliminary cohort study analysis
por: Ciani, Oriana, et al.
Publicado: (2011)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

A call for better reporting of trials using surrogate primary endpoints
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence
por: Ciani, Oriana, et al.
Publicado: (2022)

Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022)

Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study
por: Wallach, Joshua D., et al.
Publicado: (2018)

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Statistical validation of surrogate outcome measures
por: Buyse, Marc
Publicado: (2011)

Bayesian hierarchical meta‐analytic methods for modeling surrogate relationships that vary across treatment classes using aggregate data
por: Papanikos, Tasos, et al.
Publicado: (2020)

The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005)

Validity of Surrogate Endpoints and Their Impact on Coverage Recommendations: A Retrospective Analysis across International Health Technology Assessment Agencies
por: Ciani, Oriana, et al.
Publicado: (2021)

Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms
por: Ciani, Oriana, et al.
Publicado: (2018)

Physical activity and health related quality of life
por: Anokye, Nana Kwame, et al.
Publicado: (2012)

Body shape and pants size as surrogate measures of obesity among males in epidemiologic studies
por: Vallières, Eric, et al.
Publicado: (2020)

The cost-effectiveness of exercise referral schemes
por: Anokye, Nana K, et al.
Publicado: (2011)

Development features and study characteristics of mobile health apps in the management of chronic conditions: a systematic review of randomised trials
por: Cucciniello, Maria, et al.
Publicado: (2021)

Using surrogate biomarkers to improve measurement error models in nutritional epidemiology
por: Keogh, Ruth H, et al.
Publicado: (2013)

A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses
por: Xie, Wanling, et al.
Publicado: (2019)

A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials
por: Ciani, Oriana, et al.
Publicado: (2023)

Surrogate Modeling of the CLIC Final-Focus System using Artificial Neural Networks
por: Ögren, J., et al.
Publicado: (2020)

Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age
por: Mercier, Toine, et al.
Publicado: (2018)

Gaseous pollutants in particulate matter epidemiology: confounders or surrogates?
por: Sarnat, J A, et al.
Publicado: (2001)

Development of an RF-EMF Exposure Surrogate for Epidemiologic Research
por: Roser, Katharina, et al.
Publicado: (2015)

Preliminary Identification of Coping Profiles Relevant to Surrogate Decision Making in the ICU
por: Butler, Jorie M., et al.
Publicado: (2016)

Importance of final state fluctuations in radiative capture reactions and applications to surrogate reaction measurements
por: Dietrich, F S
Publicado: (2012)

Evaluation of Continuous Tumor-Size–Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
por: Burzykowski, Tomasz, et al.
Publicado: (2019)

Qualitative evidence synthesis for complex interventions and guideline development: clarification of the purpose, designs and relevant methods
por: Flemming, Kate, et al.
Publicado: (2019)

HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES: A SURVEY OF NON-EUROPEAN UNION AGENCIES
por: Ciani, Oriana, et al.
Publicado: (2015)

The role of health technology assessment bodies in shaping drug development
por: Ciani, Oriana, et al.
Publicado: (2014)

Editorial: Near-infrared fluorescence guided surgery: State of the evidence from a health technology assessment perspective
por: Bertolaccini, Luca, et al.
Publicado: (2023)

Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study
por: la Cour, Jeppe Lerche, et al.
Publicado: (2010)

Factors influencing the implementation of fall-prevention programmes: a systematic review and synthesis of qualitative studies
por: Child, Sue, et al.
Publicado: (2012)

The Final Size of a Serious Epidemic
por: Brauer, Fred
Publicado: (2018)

Disease vocabulary size as a surrogate marker for physicians’ disease knowledge volume
por: Tanaka, Hiroaki, et al.
Publicado: (2018)

Method of determining geometric patient size surrogates using localizer images in CT
por: Burton, Christiane S.
Publicado: (2020)

Implementing shared decision-making interventions in breast cancer clinical practice: a scoping review
por: Oprea, Natalia, et al.
Publicado: (2023)

Comment on The Unbearable Lightness of Difference Between Statistical and Clinical Significance
por: Bertolaccini, Luca, et al.
Publicado: (2022)

Surrogates are just surrogates, but helpful just the same
por: Fabian, Carol
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_bnasdhft93v19fojro175omrms